Related Experiment Video
Updated: Jul 16, 2026

The Superficial Inferior Epigastric Artery Axial Flap to Study Ischemic Preconditioning Effects in a Rat Model
Published on: January 27, 2023
Remote ischemic preconditioning modulates p38 MAP kinase in rat adipocutaneous flaps
R Brannon Claytor1, Nathan J Aranson, Ronald A Ignotz
1Division of Plastic and Reconstructive Surgery, University of Massachusetts Medical Center, Worcester, Massachusetts 01655, USA.
Remote ischemic preconditioning (RIPC) enhances cutaneous flap survival by increasing p38 MAP kinase phosphorylation. This protective effect is mediated by nitric oxide and can be blocked by its inhibition.
Area of Science:
- Biomedical Engineering
- Surgical Research
- Molecular Biology
Background:
- Cutaneous flap survival is critical in reconstructive surgery.
- Ischemic preconditioning (IP) is known to improve tissue survival.
- The molecular mechanisms underlying IP, particularly remote IP (RIPC), require further elucidation.
Purpose of the Study:
- To investigate the effect of RIPC on p38 MAP kinase phosphorylation.
- To correlate p38 MAP kinase activation with cutaneous flap survival in a rat model.
- To determine the role of nitric oxide in RIPC-induced protection.
Main Methods:
- Abdominal adipocutaneous flaps were raised in Wistar rats.
- RIPC was induced using a tourniquet on the contralateral hind limb.
- Groups included controls, RIPC, RIPC with nitric oxide synthase inhibition (L-NAME), and flap elevation prior to RIPC.
- Flap survival and p38 MAP kinase/phosphorylated p38 MAP kinase (pp38 MAP kinase) levels were assessed.
Main Results:
- RIPC significantly improved flap tissue survival compared to controls.
- RIPC induced well-defined phosphorylation of p38 MAP kinase (pp38 MAP kinase) post-procedure.
- Inhibition of nitric oxide with L-NAME abolished the survival benefit and reduced pp38 MAP kinase levels.
- Minimal pp38 MAP kinase was observed after prolonged ischemia.
Conclusions:
- Increased cutaneous flap survival following RIPC is correlated with elevated pp38 MAP kinase.
- Nitric oxide signaling is essential for RIPC-mediated protection and p38 MAP kinase activation.
- Modulation of the p38 MAP kinase pathway represents a potential therapeutic target for enhancing tissue survival during ischemia.
More Related Videos
11:12In situ Transverse Rectus Abdominis Myocutaneous Flap: A Rat Model of Myocutaneous Ischemia Reperfusion Injury
Published on: June 8, 2013
10:24Ischemic Tissue Injury in the Dorsal Skinfold Chamber of the Mouse: A Skin Flap Model to Investigate Acute Persistent Ischemia
Published on: November 17, 2014